Efficacy and Safety of T Cell Receptor Modified T (TCR-T) Cells in Advanced Pancreatic Cancer, Lung Cancer and Colorectal Cancer Therapy
Ontology highlight
ABSTRACT: Interventions: experimental group:TCR-T treatment
Primary outcome(s): complete response (CR);partial response (PR);stable disease (SD);progressive disease (PD);objective response rate (ORR);duration of response (DOR);tumor marker (TM);dose limited toxicity (DLT);markers of infection
Study Design: Single arm
DISEASE(S): Advanced Pancreatic Cancer, Lung Cancer And Colorectal Cancer
PROVIDER: 37438 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA